Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: Elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes

Journal of Immunology

Volumn 179, Issue 5, 2007, Pages 3012-3025

  Yee, Ling Wu ^a,b   Savelli, Stephanie L ^a,b   Yang, Yan ^a   Zhou, Bi ^a   Rovin, Brad H ^b   Birmingham, Daniel J ^b   Nagaraja, Haikady N ^b   Hebert, Lee A ^b   Yu, C Yung ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4 BINDING PROTEIN; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C4L; COMPLEMENT COMPONENT C4S; ELONGATION FACTOR 2 KINASE; GENOMIC DNA; STEROID 21 MONOOXYGENASE; TENASCIN; TENASCIN X; UNCLASSIFIED DRUG; ENDOMETRIOSIS PROTEIN 1; ENDOMETRIOSIS PROTEIN II; ENDOMETRIOSIS PROTEIN-1; GLYCOPROTEIN; HLA ANTIGEN; MEMBRANE PROTEIN; TNXA PROTEIN, HUMAN;

AMPLICON; ARTICLE; CONSANGUINITY; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DUPLICATION; GENE LINKAGE DISEQUILIBRIUM; GENE NUMBER; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HLA SYSTEM; HOMOZYGOSITY; HUMAN; MOLECULAR CLONING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; GENE DOSAGE; GENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SOUTHWESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, SOUTHWESTERN; COMPLEMENT C4; COMPLEMENT C4A; COMPLEMENT C4B; CONSANGUINITY; GENE DOSAGE; GENOTYPE; GLYCOPROTEINS; HAPLOTYPES; HLA ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STEROID 21-HYDROXYLASE; TENASCIN; VARIATION (GENETICS);

EID: 38449101999     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.5.3012     Document Type: Article

References (66)

1. Sebat, J., B. Lakshmi, J. Troge, J. Alexander, J. Young, P. Lundin, S. Maner, H. Massa, M. Walker, M. Chi, et al. 2004. Large-scale copy number polymorphism in the human genome. Science 305: 525-528.
2. Iafrate, A. J., L. Feuk, M. N. Rivera, M. L. Listewnik, P. K. Donahoe, Y. Qi, S. W. Scherer, and C. Lee. 2004. Detection of large-scale variation in the human genome. Nat. Genet. 36: 949-951.
3. Redon, R., S. Ishikawa, K. R. Fitch, L. Feuk, G. H. Perry, T. D. Andrews, H. Fiegler, M. H. Shapero, A. R. Carson, W. Chen, et al. 2006. Global variation in copy number in the human genome. Nature 444: 444-454.
4. Wong, K. K., R. J. deLeeuw, N. S. Dosanjh, L. R. Kimm, Z. Cheng, D. E. Horsman, C. MacAulay, R. T. Ng, C. J. Brown, E. E. Eichler, and W. L. Lam. 2007. A comprehensive analysis of common copy number variations in the human genome. Am. J. Hum. Genet. 80: 91-104.
5. Yang, Z., A. R. Mendoza, T. R. Welch, W. B. Zipf, and C. Y. Yu. 1999. Modular variations of HLA class III genes for serine/threonine kinase RP, complement C4, steroid 21-hydroxylase CYP21 and tenascin TNX (RCCX): a mechanism for gene deletions and disease associations. J. Biol. Chem. 274: 12147-12156.
6. Shen, L. M., L. C. Wu, S. Sanlioglu, R. Chen, A. R. Mendoza, A. Dangel, M. C. Carroll, W. Zipf, and C. Y. Yu. 1994. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and C4B genes in the HLA class III region: molecular cloning, exon-intron structure, composite retroposon and breakpoint of gene duplication. J. Biol. Chem. 269: 8466-8476.
7. Yu, C. Y., E. K. Chung, Y. Yang, C. A. Blanchong, N. Jacobsen, K. Saxena, Z. Yang, W. Miller, L. Varga, and G. Fust. 2003. Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex. Prog. Nucleic Acid Res. Mol. Biol. 75: 217-292.
8. Blanchong, C. A., B. Zhou, K. L. Rupert, E. K. Chung, K. N. Jones, J. F. Sotos, R. M. Rennebohm, and C. Y. Yu. 2000. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: the load of RCCX genetic diversity on MHC-associated disease. J. Exp. Med. 191: 2183-2196.
9. Livak, K. J., S. J. Flood, J. Marmaro, W. Giusti, and K. Deetz. 1995. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 4: 357-362.
10. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6: 986-994.
11. Walport, M. J. 2001. Complement- part II. New Engl. J. Med. 344: 1140-1144.
12. Dangel, A. W., A. R. Mendoza, B. J. Baker, C. M. Daniel, M. C. Carroll, L.-C. Wu, and C. Y. Yu. 1994. The dichotomous size variation of human complement C4 gene is mediated by a novel family of endogenous retroviruses which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 40: 425-436.
13. Yu, C. Y. 1991. The complete exon-intron structure of a human complement component C4A gene: DNA sequences, polymorphism, and linkage to the 21-hydroxylase gene. J. Immunol. 146: 1057-1066.
14. Chung, E. K., Y. Yang, R. M. Rennebohm, M. L. Lokki, G. C. Higgins, K. N. Jones, B. Zhou, C. A. Blanchong, and C. Y. Yu. 2002. Genetic sophistication of human complement C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex (MHC). Am. J. Hum. Genet. 71: 823-837.
15. Yu, C. Y., Z. Yang, C. A. Blanchong, and W. Miller. 2000. The human and mouse MHC class III region: a parade of the centromeric segment with 21 genes Immunol. Today 21: 320-328.
16. Gitelman, S. E., J. Bristow, and W. L. Miller. 1992. Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus. Mol. Cell. Biol. 12: 2124-2134.
17. Higashi, Y., H. Yoshioka, M. Yamane, O. Gotoh, and Y. Fujii-Kuriyama. 1986. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc. Natl. Acad. Sci. USA 83: 2841-2845.
18. Yu, C. Y., and R. D. Campbell. 1987. Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles. Immunogenetics 25: 383-390.
19. Yang, Y., E. K. Chung, B. Zhou, C. A. Blanchong, C. Y. Yu, G. Füst, M. Kovács, A. Vatay, C. Szalai, I. Karádi, and L. Varga. 2003. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities and body mass index. J. Immunol. 171: 2734-2745.
20. Yang, Y., E. K. Chung, Y. L. Wu, S. L. Savelli, H. N. Nagaraja, B. Zhou, M. Hebert, K. N. Jones, Y. Shu, K. Kitzmiller, et al. 2007. Gene copy number variation and associated polymorphisms of complement component C4 in human systemic erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against European American SLE disease susceptibility. Am. J. Hum. Genet. 80: 1037-1054.
21. Yang, Y., E. K. Chung, B. Zhou, K. Lhotta, L. A. Hebert, D. J. Birmingham, B. H. Rovin, and C. Y. Yu. 2004. The intricate role of complement C4 in human systemic lupus erythematosus. Curr. Dir. Autoimmun. 7: 98-132.
22. Fielder, A. H. L., M. J. Walport, J. R. Batchelor, R. I. Rynes, C. M. Black, I. A. Dodi, and G. R. V. Hughes. 1983. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br. Med. J. 286: 425-428.
23. Bishof, N. A., T. R. Welch, and L. S. Beischel. 1990. C4B Deficiency: a risk factor for bacteremia with encapsulated organisms. J. Infect. Dis. 162: 248-250.
24. Dawkins, R., C. Leelayuwat, S. Gaudieri, G. Tay, J. Hui, S. Cattley, P. Martinez, and J. Kulski. 1999. Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol. Rev. 167: 275-304.
25. Martinez, O. P., N. Longman-Jacobsen, R. Davies, E. K. Chung, Y. Yang, S. Gaudieri, R. L. Dawkins, and C. Y. Yu. 2001. Genetics of human complement component C4 and evolution the central MHC. Front. Biosci. 6: D904-D913.
26. Awdeh, Z. L., D. Raum, E. J. Yunis, and C. A. Alper. 1983. Extended HLA/ complement allele haplotypes: Evidence for T/t-like complex in man. Proc. Natl. Acad. Sci. USA 80: 259-263.
27. de Bakker, P. I., G. McVean, P. C. Sabeti, M. M. Miretti, T. Green, J. Marchini, X. Ke, A. J. Monsuur, P. Whittaker, M. Delgado, et al. 2006. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38: 1166-1172.
28. Graham, R. R., W. A. Ortmann, C. D. Langefeld, D. Jawaheer, S. A. Selby, P. R. Rodine, E. C. Baechler, K. E. Rohlf, K. B. Shark, K. J. Espe, et al. 2002. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71: 543-553.
29. Tiwari, J. L., and P. I. Terasaki. 1985. HLA and Disease Associations. Springer-Verlag, New York.
30. Thorsby, E. 1997. HLA associated diseases. Hum. Immunol. 53: 1-11.
31. Horton, R., L. Wilming, V. Rand, R. C. Lovering, E. A. Bruford, V. K. Khodiyar, M. J. Lush, S. Povey, C. C. Talbot, Jr., M. W. Wright, et al. 2004. Gene map of the extended human MHC. Nat. Rev. Genet. 5: 889-899.
32. Stewart, C. A., R. Horton, R. J. Allcock, J. L. Ashurst, A. M. Atrazhev, P. Coggill, I. Dunham, S. Forbes, K. Halls, J. M. Howson, et al. 2004. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 14: 1176-1187.
33. Traherne, J. A., R. Horton, A. N. Roberts, M. M. Miretti, M. E. Hurles, C. A. Stewart, J. L. Ashurst, A. M. Atrazhev, P. Coggill, S. Palmer, et al. 2006. Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet. 2: e9.
34. Schneider, P. M., M. C. Carroll, C. A. Alper, C. Rittner, A. S. Whitehead, E. J. Yunis, and H. R. Colten. 1986. Polymorphism of human complement C4 and steroid 21-hydroxylase genes: restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J. Clin. Invest. 78: 650-657.
35. Chung, E. K., Y. Yang, K. L. Rupert, K. N. Jones, R. M. Rennebohm, C. A. Blanchong, and C. Y. Yu. 2002. Determining the one, two, three or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding for C4A or C4B proteins. Am. J. Hum. Genet. 71: 810-822.
36. Chung, E. K., Y. L. Wu, Y. Yang, B. Zhou, and C. Y. Yu. 2005. Human complement components C4A and C4B genetic diversities: complex genotypes and phenotypes. In Current Protocols in Immunology. J. E. Coligan, B. E. Bierer, D. H. Margulis, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, Edison, NJ, pp. 13.8.1-13.8.36.
37. Yu, C. Y., C. A. Blanchong, E. K. Chung, K. L. Rupert, Y. Yang, Z. Yang, B. Zhou, and J. M. Moulds. 2002. Molecular genetic analyses of human complement components C4A and C4B. In Manuals of Clinical Laboratory Immunology. N. R. Rose, R. G. Hamilton, and B. Detrick, eds. ASM Press, Washington, DC, pp. 117-131.
38. Uejima, H., M. P. Lee, H. Cui, and A. P. Feinberg. 2000. Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios. Nat. Genet. 25: 375-376.
39. Carroll, M. C., R. D. Campbell, D. R. Bentley, and R. R. Porter. 1984. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 307: 237-241.
40. Yang, Z., L. Shen, A. W. Dangel, L. C. Wu, and C. Y. Yu. 1998. Four ubiquitously expressed genes. RD (D6S45)-SKI2W (SKIV2L)-DOM3Z-RP1(D6S60E), are present between complement component genes factor B and C4 in the class III region of the HLA. Genomics 53: 338-347.
41. Carroll, M. C., A. Palsdottir, K. T. Belt, and R. R. Porter. 1985. Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J. 4: 2547-2552.
42. Yu, C. Y., and C. Milstein. 1989. A physical map linking the five CD1 human thymocyte differentiation antigen genes. EMBO J. 8: 3727-3732.
43. Yu, C. Y., L. C. Wu, L. Buluwela, and C. Milstein. 1993. Cosmid cloning and walking to map human CD1 leucocyte differentiation genes. Methods Enzymol. 217: 378-398.
44. Lo, A. K., K. W. Lo, S. W. Tsao, H. L. Wong, J. W. Hui, K. F. To, D. S. Hayward, Y. L. Chui, Y. L. Lau, K. Takada, and D. P. Huang. 2006. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 8: 173-180.
45. Awdeh, Z. L., D. Raum, and C. A. Alper. 1979. Genetic polymorphism of human complement C4 and detection of heterozygotes. Nature 282: 205-208.
46. O'Neill, G. J., S. Y. Yang, and B. DuPont. 1978. Two HLA-linked loci controlling the fourth component of human complement. Proc. Natl. Acad. Sci. USA 75: 5165-5169.
47. Roos, M. H., E. Mollenhauer, P. Demant, and C. Rittner. 1982. A molecular basis for the two locus model of human complement component C4. Nature 298: 854-855.
48. Awdeh, Z. L., D. Raum, E. J. Yunis, and C. A. Alper. 1983. Extended HLA/ complement allele haplotypes: evidence for T/t-like complex in man. Proc. Natl. Acad. Sci. USA 80: 259.
49. Illei, G. G., E. Tackey, L. Lapteva, and P. E. Lipsky. 2004. Biomarkers in systemic lupus erythematosus, I: general overview of biomarkers and their applicability. Arthritis Rheum. 50: 1709-1720.
50. Illei, G. G., E. Tackey, L. Lapteva, and P. E. Lipsky. 2004. Biomarkers in systemic lupus erythematosus, II: markers of disease activity. Arthritis Rheum. 50: 2048-2065.
51. Liu, C. C., S. Manzi, and J. M. Ahearn. 2005. Biomarkers for systemic lupus erythematosus: a review and perspective. Curr. Opin. Rheumatol. 17: 543-549.
52. Szilagyi, A., B. Blasko, D. Szilassy, G. Fust, M. Sasvari-Szekely, and Z. Ronai. 2006. Real-time PCR quantification of human complement C4A and C4B genes. BMC Genet. 7: 1-9.
53. Falus, A., J. Kramer, E. Walcz, Z. Varga, J. Setalo, K. Jobst, T. Lakatos, and K. Meretey. 1989. Unequal expression of complement C4A and C4B genes in rheumatoid synovial cells, human monocytoid and hepatoma-derived cell lines. Immunology 68: 133-136.
54. Tsukamoto, H., K. Nagasawa, S. Yoshizawa, Y. Tada, A. Ueda, Y. Ueda, and Y. Niho. 1992. Synthesis and regulation of the fourth component of complement (C4) in the human momocytic cell line U937: comparison with that of the third component of complement. Immunology 75: 565-569.
55. Mauff, G., B. Luther, P. M. Schneider, C. Rittner, B. Strandmann-Bellinghausen, R. Dawkins, and J. M. Moulds. 1998. Reference typing report for complement component C4. Exp. Clin. Immunogenet. 15: 249-260.
56. Isenman, D. E., and J. R. Young. 1984. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J. Immunol. 132: 3019-3027.
57. Dodds, A. W., S. K. Law, and R. R. Porter. 1985. The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6. EMBO J. 4: 2239-2244.
58. Dodds, A. W., X.-D. Ren, A. C. Willis, and S. K. A. Law. 1996. The reaction mechanism of the internal thioester in the human complement component C4. Nature 379: 177-179.
59. Yu, C. Y., R. D. Campbell, and R. R. Porter. 1988. A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement C4A/C4B isotypes. Immunogenetics 27: 399-405.
60. Wu, Y. L., G. C. Higgins, R. M. Rennebohm, E. K. Chung, Y. Yang, B. Zhou, N. Nagaraja, D. J. Birmingham, B. H. Rovin, L. A. Hebert, and C. Y. Yu. 2006. Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects. Adv. Exp. Med. Biol. 586: 227-247.
61. Blanchong, C. A., E. K. Chung, K. L. Rupert, Y. Yang, Z. Yang, B. Zhou, and C. Y. Yu. 2001. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologs, Slp and C4. Int. Immunopharmacol. 1: 365-392.
62. White, P. C., A. Vitek, B. DuPont, and M. I. New. 1988. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. USA 85: 4436-4440.
63. Yu, C. Y., and C. C. Whitacre. 2004. Sex, MHC and complement C4 in autoimmune diseases. Trends Immunol. 25: 694-699.
64. Price, P., C. Witt, R. Allcock, D. Sayer, M. Garlepp, C. C. Kok, M. French, S. Mallal, and F. Christiansen. 1999. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167: 257-274.
65. Jahn, I., J. E. Mejia, M. Thomas, C. Darke, H. Schroder, G. Geserick, and G. Hauptmann. 1994. Genomic analysis of the F subtypes of human complement factor B. Eur. J. Immunogenet. 21: 415-423.
66. Jahn, I., B. Uring-Lambert, D. Arnold, S. Clemenceau, and G. Hauptmann. 1990. C2 reference typing report. Complement Inflamm. 7: 175-182.